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Petroleum jelly—a semisolid form of paraffin—was used for the first time in 1899. Then, because of its relatively low melting point (40°C), it has 
been replaced by more solid paraffin as a filler of tissue 
defects, wrinkles, and breasts. The immediate satisfac-
tory results on a cosmetic level, the low cost, and the 
painless character have encouraged its rapid diffusion.
After a decade, however, complications like tissue 
necrosis, fat embolism, skin ulceration, infection, 
etc. were reported. In Kolle’s1 book, entitled Plastic 
and Cosmetic Surgery, a whole chapter was devoted to 
complications of paraffin injection into breast tissue. 
These complications ranged from cosmetic failure 
to death, and most of them required mastectomy. In 
1926, Lyons and Hunt2 described the paraffin injec-
tions as an “inexcusable practice.”
Two decades later, the use of petrolatum and par-
affin has been abandoned for breast augmentation 
in Western countries. In other countries, however, its 
use has continued into the fifties and beyond, despite 
the ongoing publications of serious complications.3,4 
Finally, the medical profession abandoned the use of 
paraffin for breast augmentation after 1975. Some 
observations indicate, however, that patients them-
selves performed these injections.5 Surprisingly, we 
report a very recent case of paraffin injections by a 
physician, attesting to the persistence of this practice 
in some countries.
OBSERVATION
A 39-year-old patient consulted in 2011 in the 
University Hospital of Strasbourg for tense and 
painful breasts after an injection of petrolatum in 
Chechnya 2 years ago to increase her breast size. 
The patient gradually developed bilateral edema 
and erythema. In addition, the patient described 
fever episodes evolving repeatedly and associated 
with a major weakness. The clinical breast exami-
nation found erythematosus plates in the upper 
and internal regions without ulceration or fistula 
consequences (Fig. 1A).
The mammogram showed multiple rounded 
masses of fat density, confluent and disseminated 
over dense breasts (Fig. 1B). At the ultrasound, 
there were multiple thin-walled cystic formations 
of anechoic content. The fine-needle aspiration 
confirmed the presence of an oily liquid. The 
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Summary: Paraffin and petrolatum have been known for more than 100 
years as volumizing products. Certain countries still use them despite impor-
tant complications. The authors report the case of a 39-year-old patient pre-
senting a bilateral oleogranulomatous mastitis. An injection of petrolatum 
had been realized 2 years ago in Chechnya for cosmetic reasons. Clinically, 
she presented dense, erythemic, and painful breasts. The radiological exami-
nation found diffuse oily cysts. After first abdominal expansion, a bilateral 
mastectomy with immediate reconstruction was performed. The authors 
present a literature review about the clinical and radiological data and the 
possible treatments, and underline the numerous risks of this procedure, 
which should be strictly forbidden. (Plast Reconstr Surg Glob Open 2015;3:e536; 
doi: 10.1097/GOX.0000000000000513; Published online 14 October 2015.)
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magnetic resonance imaging showed diffusely 
infiltrated breasts with multiple cysts. The images 
were enhanced after gadolinium injection.
Aspiration followed by liposuction was tried to 
eliminate petrolatum, but without any result, the 
breasts being too fibrous and petrolatum too diffuse. 
After prolonged anti-inflammatory and antibiotic 
treatment, the patient agreed to a bilateral mastecto-
my. Given the extent of resection, immediate breast 
reconstruction was impossible without prior tissue 
expansion. Abdominal expansion by saline inflat-
able implants was performed (Fig. 1C). The prosthe-
ses volume was 1 L per side. Inflation was performed 
once a week. The prostheses were overinflated and 
left in place for 3 and a half months. The second in-
tervention consisted of a bilateral mastectomy with-
out preservation of the nipple-areolar plates, which 
were too adherent and inflammatory. The gland 
and the pectoralis major muscle were infiltrated, fi-
brous, and altered. The removed mammary glands 
weighed 930–950 g. Histological examination of the 
breasts confirmed the diagnosis of oleogranuloma-
tous mastitis (OM). Immediate breast reconstruc-
tion was obtained by expansion and advancement 
of abdominal flap. To avoid excessive skin tension, 
inflatable breast expanders were introduced at the 
retro pectoral level. Three months later, expanders 
were removed and replaced by permanent silicone 
protheses with an anatomical shape of 520 g.
The nipple-areolar complex was reconstructed 
later by transplantation of the earlobe and tattoo. 
The postoperative course was uneventful. Today, the 
patient has no longer pain or inflammation or fe-
ver. The cosmetic result is satisfactory, despite a per-
sistent erythematous area in the upper pole of the 
breasts (Fig. 1D).
DISCUSSION
Our observation is consistent with a recent injec-
tion of paraffin, as evidenced by history and radio-
Fig. 1. a, preoperative clinical appearance of both breasts. Bilateral erythematous plates of the upper and internal regions 
are found without ulcers or fistula sequelae. Breasts are very tense. B, Mammographic appearance of both breasts viewed 
from the front showing multiple small lights scattered throughout the mammary gland, although limited and noncalcified 
with a predilection for retro grandular and prepectoral regions. C, an abdominal expansion by saline inflatable implants 
was performed (prostheses volume: 1 L per side) and left in place for 3 and a half months. D, Front final aspect and after 
reconstruction of nipple-areolar plates. there remains an erythematous area in the upper pole of the breast.
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graphic appearance of the breasts. Indeed, recent 
injections result in multiple small lights scattered 
throughout the mammary gland, although limited 
and noncalcified.6 In contrast, former injections are 
characterized by dense masses with semicircular or 
“soap–bubble-like” calcifications.7
Considering the fact that paraffin injections were 
recent, we tried to avoid in the first-place mastec-
tomy, using liposuction of oily masses. But, because 
of the inflammatory and hypervascular nature of the 
tissue on the one hand and of the small oily masses 
and their diffuse nature on the other hand, the at-
tempt was unsuccessful.
For many authors, mastectomy is the only cura-
tive treatment. In Alagaratnam and Ng’s8 series of 
43 patients, where the injections were recent or very 
old (realized between 3 and 41 years ago), 30 mas-
tectomies had to be performed because of the im-
portance of the masses and chronic ulcerations. Ho 
et al9 reported 8 patients cared for OM (injections 
performed between 11 and 30 years ago). In one case, 
the injection of paraffin was followed by destructive 
ulceration of the anterior chest wall, with damage 
to both pectoral muscles and the ribs. The author 
also concluded that the only possible treatment for 
OM was mastectomy, which might be associated with 
first-stage reconstruction by rectus abdominal mus-
culocutaneous flap. Ortiz-Monasterio and Trigos10 
propose second-stage breast reconstruction due to 
the risk of bleeding and infections.
In our case, mastectomy with conservation of 
the skin would have resulted in a thin skin cover-
ing the implant, with increased risk of exposure of 
the prosthesis. To reduce the risk of complications, 
we performed an original method for abdominal 
expansion to provide healthy skin to the implant. 
Reconstruction is cosmetically satisfactory, but a rash 
persists in the upper quadrants.
CONCLUSION
OM is a challenge for surgeons. Therapeutic 
problems are indeed encountered because patients 
attach great importance to the cosmetic result, and 
paraffin injections have been devised for aesthetic 
reasons. Patients also pose psychological difficul-
ties because they do not understand the seriousness 
of the problem and do not accept mutilation for a 
benign lesion. No treatment is able to modify the 
course of the OM, which may be accompanied by 
skin ulceration or parietal necrosis. We have shown 
that liposuction of paraffin is impossible. Mastectomy 
is the only treatment, possibly associated with imme-
diate breast reconstruction or delayed. The injection 
of paraffin or petrolatum leads to real dilapidations, 
and for that reason must be firmly prohibited.
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